Synthesis of fluorinated cyclic s-trans vinylogous acid and amide ester derivatives

Tetrahedron Letters

Volumn 47, Issue 42, 2006, Pages 7451-7454

  Okoro, Cosmas O ^a   Fadeyi, Olugbeminiyi O ^a   Jackson, Patrice L ^a   Richmond, Rhonda L ^a   Farmer, Takeisha ^a  

^a TENNESSEE STATE UNIVERSITY   (United States)

Author keywords

Cyclic enaminone; Michael acceptors; MOPAC; s trans; Trifluoromethyl; Vinylogous

Indexed keywords

4 HYDROXYPHENYLPYRUVATE DIOXYGENASE; AMIDE; ANTICONVULSIVE AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ANTIPARASITIC AGENT; CELECOXIB; CHOLINESTERASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; EFAVIRENZ; ENAMINONE; ENZYME INHIBITOR; ESTER DERIVATIVE; FLUOXETINE; FLUPHENAZINE; FLUTAMIDE; HETEROCYCLIC COMPOUND; NATURAL PRODUCT; NILUTAMIDE; ORGANIC COMPOUND; OXYTOCIN ANTAGONIST; POTASSIUM CHANNEL STIMULATING AGENT; TOLRESTAT; UNCLASSIFIED DRUG; VINYLOGOUS ACID;

ARTICLE; CHEMICAL REACTION; CHEMICAL STRUCTURE; FLOW RATE; FLUORINATION; GAS CHROMATOGRAPHY; MASS SPECTROMETRY; SYNTHESIS; THIN LAYER CHROMATOGRAPHY;

EID: 33748427321     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2006.08.046     Document Type: Article

References (48)

1. Ren J., Milton J., Weaver K.L., Short S.A., Stuart D.I., and Stammers D.K. Structure 8 (2000) 1089-1094
2. Pedersen O.S., and Pedersen E.B. Synthesis (2000) 479-495
3. Jackson L.M., and Hawkey C.J. Drugs 59 (2000) 1207-1216
4. Price M.L.P., and Jorgensen W.J. J. Am. Chem. Soc. 122 (2000) 9455-9466
5. Neri R., and Kassem N. In: Brescianti F., et al. (Ed). Progress in Cancer Research and Therapy Vol. 31 (1984), Raven Press, New York 507
6. Allen R.C. Annu. Rep. Med. Chem. 23 (1988) 338
7. Elliot A.J. In: Filler R., and Kobayashi Y. (Eds). Biomedical Aspects of Fluorine Chemistry (1992), Elsevier, New York 55
8. Nagata M., and Robinson Jr. W.G. Invest. Ophthalmol. Vis. Sci. 28 (1987) 1867
9. Masson E.A., and Boulton A.J.M. Drugs 39 (1990) 190
10. Benfield P., Heel R.C., and Lewis S.P. Drugs 32 (1986) 481
11. Welch J.T. In: Welch J.T. (Ed). The effects of selective fluorination in organic and bioorganic chemistry. ACS Symposium Series 456 (1991), ACS, Washington DC 1-15 and references cited therein
12. McClinton M.A., and McClinton D.A. Tetrahedron 48 (1992) 6555-6666
13. Prakash G.K.S., and Yudin A.K. Chem. Rev. 97 (1997) 757-786
14. Zymalkowski F., and Rimek J. Naturwissenschaften 47 (1960) 83
15. Nitta M., Soeda H., and Iino Y. Bull. Chem. Soc. Jpn. 63 (1990) 932-934
16. Fernández M., Cuesta E., and Avendaño C. Heterocycles 38 (1994) 2615-2620
17. Mulamba T., Boukili-Garrè R.E., Sèraphin D., Noè E., Charlet-Fagnère C., Hènin J., Laronze J., Sapi J., Barret R., Laronze J.-Y., and Lèvy J. Heterocycles 41 (1995) 29-36
18. Singh K., and Singh H. Tetrahedron 54 (1998) 935-942
19. Pyrko A.N. Chem. Heterocycl. Compd. 35 (1999) 688-694
20. (i). Miyabara H., Takayasu T., and Nitta M. Heterocycles 51 (1999) 983-987
21. (ii). Miyabara H., Takayasu T., and Nitta M. J. Chem. Soc., Perkin Trans. 1 (1999) 3199-3205
22. Albright J.D., and Du X. J. Heterocycl. Chem. 37 (2000) 41-46
23. Nitta M., Mori S., and Iino Y. Heterocycles 32 (1991) 23-28
24. Amougay A., Pete J.-P., and Piva O. Tetrahedron Lett. 33 (1992) 7347-7350
25. Bartoli G., Cimarelli C., and Palmieri G. J. Chem. Soc., Perkin Trans. 1 (1994) 537-543
26. Collet S.C., Rèmi J.-F., Cariou C., Laib S., Guingant A.Y., Vu N.Q., and Dujardin G. Tetrahedron Lett. 45 (2004) 4911-4915
27. Jean-Claude G., Henri-Philippe H., and Trion Y. J. Org. Chem. 50 (1985) 5517-5520
28. Lee M.D., Fantini A.A., Morton G.O., James J.C., Borders D.B., and Testa R.T. J. Antibiot. 37 (1984) 1149
29. Hans-Jürgen G., Norbert A.B., and Dietrich S. Tetrahedron 60 (2000) 8137-8141
30. Marisa M., and Josep B. Tetrahedron 61 (2005) 8264-8270
31. Micheal J.P., Koning C.B., and Gravestock D. J. Chem. Soc., Perkin Trans. 1 (2000) 1919
32. Imber Flores M., and Urich B. Tetrahedron Lett. 37 (1996) 1007-1010
33. In: Crumplin G.C. (Ed). The 4-Quinolones: Anti bacterial Agents In Vitro (1990), Springer, London
34. Appelbaum F.C., and Hunter P.A. Int. J. Antimicrob. Agents 16 (2000) 5-15
35. Eddington N.D., Cox D.S., Roberts R.R., Stables J.P., Powell C.B., and Scott K.R. Curr. Med. Chem. 7 (2000) 417-436
36. Carrol W.A., Altenbach R.J., Bai H., Brioni J.D., Brune M.E., Buckner S.A., Cassidy C., Chen Y., Coghlan M.J., Daza A.V., Drizin I., Fey T.A., Fitzgerald M., Gopalakrishnan M., Gregg R.J., Henry R.F., Holladay M.W., King L.L., Kort M.E., Kym P.R., Milicic I., Tang R., Turner S.C., Whiteaker K.L., Yi L., Zhang H., and Sullivan J.P. J. Med. Chem. 47 (2004) 3163-3179
37. Boger D.L., Ishizaki T., Wysocki Jr. R.J., Munk S.A., Kitos P.A., and Suntornwat O. J. Am. Chem. Soc. 111 (1989) 6461-6463
38. Lindstedt S., Holme E., Lock E., Hialmarson O., and Strandvik B. Lancet 340 (1992) 813
39. Lin, S.-W.; Lin, Y.-L.; T.-C.; Yang, D.-Y. Bioorg. Med. Chem. Lett. 2000, 10, 1297.
40. Bradley W.C., Juan C.J., Lawrence D.W., Thomas G.H., Thomas A.P., Leonard T.M., and Masood P. J. Med. Chem. 34 (1991) 2736-2746
41. Gatta F., Del Giudice M.R., Pomponi M., and Marta M. Heterocycles 34 (1992) 991-1004
42. Mohamed A., and Bayaumy B.M. Bioorg. Med. Chem. 13 (2005) 6133-6144
43. Bell I.M., Erb J.M., Freidinger R.M., Gallicchio S.N., Guare J.P., Guidotti M.T., Halpin R.A., Hobbs D.W., Homnick C.F., Kuo M.S., Lis E.V., Mathre D.J., Michelson S.R., Pawluczyk J.M., Pettibone D.J., Reiss D.R., Vickers S., Williams P.D., and Woyden C.J. J. Med. Chem. 41 (1998) 2146-2163
44. +).
45. Edafiogho I.O., Hinko C.H., Moore J.A., Mulzac D., Nichlson J.M., and Scott K.R. J. Med. Chem. 25 (1992) 2798-2805
46. Friary R.J., Gilligan J.M., Szajewski R.P., Falci K.J., and Franck R.W. J. Org. Chem. 38 (1973) 3487-3490
47. The structures for the Michael acceptors were built using BioMedCAche v. 6.1 (Fujitsu, Sunnyvale CA) and were refined by carrying out geometry optimization calculations in MOPAC using AMI parameters. The LUMO energy was determined after optimization of the molecular geometry of each acceptor molecule, by first using augmented MM2, then using MOPAC with PM3 parameters.
48. Foster J.E., Nicholson J.M., Butcher R., Stables J.P., Edafiogho I., Goodwin A.M., Henson M.C., Smith C.A., and Scott K.R. Bioorg. Med. Chem. 7 (1999) 2415-2425